Announcements


Filters [Clear]
  • Company Code: CUV (ASX)
CUV Update - Notification of buy-back - CUV18/03/24 download Created with Sketch. 13.65KB
CUV Notification of buy-back - CUV14/03/24 download Created with Sketch. 13.06KB
CUV CLINUVEL initiates on market share buy-back programPRICE SENSITIVE14/03/24 download Created with Sketch. 89.87KB
CUV New case of SCENESSE efficacy in vitiligo presented at AADPRICE SENSITIVE11/03/24 download Created with Sketch. 362.39KB
CUV SCENESSE Presented at American Academy of Dermatology08/03/24 download Created with Sketch. 74.91KB
CUV Ceasing to be a substantial holder05/03/24 download Created with Sketch. 1.12MB
CUV SCENESSE provides photoprotection in variegate porphyriaPRICE SENSITIVE04/03/24 download Created with Sketch. 195.58KB
CUV Becoming a substantial holder28/02/24 download Created with Sketch. 1.69MB
CUV Final Director's Interest Notice27/02/24 download Created with Sketch. 188.5KB
CUV Half Year Results Webinar Recording23/02/24 download Created with Sketch. 58.64KB
CUV CLINUVEL Delivers Increased Revenues, Solid Earnings22/02/24 download Created with Sketch. 107.14KB
CUV CUV Appendix 4D Half Year ReportPRICE SENSITIVE22/02/24 download Created with Sketch. 570.89KB
CUV Director Resignation21/02/24 download Created with Sketch. 67.94KB
CUV CEO Letter to Shareholders16/02/24 download Created with Sketch. 103.23KB
CUV Half Year Results Investor Webinar16/02/24 download Created with Sketch. 59.78KB
CUV Change in substantial holding31/01/24 download Created with Sketch. 1.58MB
CUV CLINUVEL Newsletter 1 - January 202416/01/24 download Created with Sketch. 256.64KB
CUV Chair Elect Letter14/12/23 download Created with Sketch. 106.04KB
CUV Change to Registered Office07/12/23 download Created with Sketch. 129.35KB
CUV Notification of cessation of securities - CUV27/11/23 download Created with Sketch. 21.49KB
CUV Change of Director's Interest Notice27/11/23 download Created with Sketch. 526.02KB
CUV Application for quotation of securities - CUV27/11/23 download Created with Sketch. 25.55KB
CUV CLINUVEL Newsletter V - November 202324/11/23 download Created with Sketch. 481.47KB
CUV Sydney Vitiligo Presentation10/11/23 download Created with Sketch. 874.94KB
CUV Final Director's Interest Notice02/11/23 download Created with Sketch. 190.98KB
CUV CLINUVEL Appoints New Chair31/10/23 download Created with Sketch. 135.75KB
CUV Results of Meeting31/10/23 download Created with Sketch. 276.04KB
CUV CEO Presentation AGM31/10/23 download Created with Sketch. 1.94MB
CUV Chair's Address31/10/23 download Created with Sketch. 160.97KB
CUV CLINUVEL starts global Phase III vitiligo study18/10/23 download Created with Sketch. 233.67KB
CUV CLINUVEL Newsletter IV - October 202306/10/23 download Created with Sketch. 245.17KB
CUV Board Changes after AGM29/09/23 download Created with Sketch. 141.26KB
CUV Notice of Annual General Meeting/Proxy Form29/09/23 download Created with Sketch. 577.45KB
CUV Change of Director's Interest Notice20/09/23 download Created with Sketch. 321.36KB
CUV CEO Letter to Shareholders19/09/23 download Created with Sketch. 192.64KB
CUV CLINUVEL Confirms AGM Date13/09/23 download Created with Sketch. 117.29KB
CUV CLINUVEL Vitiligo Expert Panel12/09/23 download Created with Sketch. 217.38KB
CUV SCENESSE in Adolescent EPP Study05/09/23 download Created with Sketch. 228.91KB
CUV CLINUVEL Investor Webinar Transcript30/08/23 download Created with Sketch. 895.6KB
CUV Appendix 4G and Corporate Governance Statement29/08/23 download Created with Sketch. 579.18KB
CUV CLINUVEL delivering increases in annual revenue, profit29/08/23 download Created with Sketch. 271.69KB
CUV Dividend/Distribution - CUV29/08/23 download Created with Sketch. 22.38KB
CUV Appendix 4E and Annual Report to Shareholders 2023PRICE SENSITIVE29/08/23 download Created with Sketch. 12.68MB
CUV Annual Results Investor Webinar - time28/08/23 download Created with Sketch. 131.05KB
CUV Technical Note - CUV151 results DNA Damage15/08/23 download Created with Sketch. 365.52KB
CUV afamelanotide reduces DNA damage in healthy population15/08/23 download Created with Sketch. 203.48KB
CUV SCENESSE applied under 5 year US Veterans Affairs contract26/07/23 download Created with Sketch. 140.08KB
CUV CLINUVEL secures IP for melanocortins to treat CNS disorders14/07/23 download Created with Sketch. 641.45KB
CUV Notification regarding unquoted securities - CUV30/06/23 download Created with Sketch. 25.38KB
CUV Two Grounds of Appeal Upheld by NICE Panel30/06/23 download Created with Sketch. 112.15KB
CUV Notification of cessation of securities - CUV29/06/23 download Created with Sketch. 21.48KB
CUV Presentation - Melbourne Twilight Briefing29/06/23 download Created with Sketch. 1.08MB
CUV Change of Director's Interest Notice28/06/23 download Created with Sketch. 313.22KB
CUV CLINUVEL Newsletter III - June 202326/06/23 download Created with Sketch. 303.33KB
CUV Strategic Update VI01/06/23 download Created with Sketch. 1.84MB
CUV PRENUMBRA administered to moderate & severe stroke patients09/05/23 download Created with Sketch. 165.07KB
CUV Expansion of global porphyria programs01/05/23 download Created with Sketch. 136.22KB
CUV CLINUVEL Newsletter II - April 202305/04/23 download Created with Sketch. 425.3KB
CUV Investor Presentation - NYC Nasdaq Event30/03/23 download Created with Sketch. 4.12MB
CUV Technical Note - CUV803 Study and AIS20/03/23 download Created with Sketch. 444.01KB
CUV First stroke patient treated with PRENUMBRA Instant20/03/23 download Created with Sketch. 271.53KB
CUV DNA Repair data presented at AAD Meeting17/03/23 download Created with Sketch. 119.77KB
CUV Statement on Silicon Valley Bank13/03/23 download Created with Sketch. 89.95KB
CUV Proposed issue of securities - CUV10/03/23 download Created with Sketch. 24.54KB
CUV Commercial Update SCENESSE09/03/23 download Created with Sketch. 127.84KB
CUV Relief from Quarterly Reporting02/03/23 download Created with Sketch. 82.33KB
CUV CLINUVEL launches first dermatocosmetic product01/03/23 download Created with Sketch. 254.92KB
CUV Proposed issue of securities - CUV28/02/23 download Created with Sketch. 24.53KB
CUV Global SCENESSE demand drives increased revenues, earnings24/02/23 download Created with Sketch. 165.94KB
CUV CUV Appendix 4D Half Year ReportPRICE SENSITIVE24/02/23 download Created with Sketch. 874.85KB
CUV PRENUMBRA formulation completed for clinical trial use15/02/23 download Created with Sketch. 257.84KB
CUV Chair's Letter09/02/23 download Created with Sketch. 215.25KB
CUV Technical note - CUV151 results02/02/23 download Created with Sketch. 370.66KB
CUV Afamelanotide reduces UV skin damage in a healthy population02/02/23 download Created with Sketch. 168.07KB
CUV Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE31/01/23 download Created with Sketch. 229.38KB
CUV NEURACTHEL manufacturing processes advance23/01/23 download Created with Sketch. 359.1KB
CUV Technical Note - Xeroderma Pigmentosum16/01/23 download Created with Sketch. 609.83KB
CUV afamelanotide Reduces DNA Photodamage in XP16/01/23 download Created with Sketch. 333.77KB
CUV CLINUVEL Newsletter I - January 202310/01/23 download Created with Sketch. 510.39KB
CUV CLINUVEL Newsletter VI - December 202223/12/22 download Created with Sketch. 246.06KB
CUV Notification of cessation of securities - CUV21/12/22 download Created with Sketch. 21.48KB
CUV Presentation - Jefferies London Healthcare Conference17/11/22 download Created with Sketch. 3.31MB
CUV CLINUVEL Newsletter V - November 202209/11/22 download Created with Sketch. 546.94KB
CUV Change of Director's Interest Notice07/11/22 download Created with Sketch. 216.26KB
CUV Quarterly Activities/Appendix 4C Cash Flow Report Re-issuedPRICE SENSITIVE31/10/22 download Created with Sketch. 348.75KB
CUV Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE31/10/22 download Created with Sketch. 347.86KB
CUV Results of Meeting26/10/22 download Created with Sketch. 144.34KB
CUV Chair Address26/10/22 download Created with Sketch. 321.32KB
CUV Melbourne Investor Briefing Presentation21/10/22 download Created with Sketch. 2.68MB
CUV First vitiligo patient enrolled in monotherapy study20/10/22 download Created with Sketch. 151.05KB
CUV Investor Presentation - Sydney14/10/22 download Created with Sketch. 3.31MB
CUV Notice of Annual General Meeting/Proxy Form23/09/22 download Created with Sketch. 3.86MB
CUV Strategic Update V19/09/22 download Created with Sketch. 408.93KB
CUV Presentation - HC Wainright Global Investment Conference13/09/22 download Created with Sketch. 869KB
CUV Annual General Meeting Date08/09/22 download Created with Sketch. 391.42KB
CUV CLINUVEL submits label expansion for adolescent EPP patients05/09/22 download Created with Sketch. 157.73KB
CUV S&P DJI Announces September 2022 Quarterly RebalancePRICE SENSITIVE02/09/22 download Created with Sketch. 134KB
CUV CLINUVEL Investor Webinar Financial Results 202231/08/22 download Created with Sketch. 2.1MB
CUV Appendix 4G and Corporate Governance Statement30/08/22 download Created with Sketch. 2.57MB
CUV Revenue Growth Drives CLINUVEL's Full Year Profit30/08/22 download Created with Sketch. 309.29KB
CUV Update - Notification of buy-back - CUV
18/03/24 download Created with Sketch. 13.65KB
CUV Notification of buy-back - CUV
14/03/24 download Created with Sketch. 13.06KB
CUV CLINUVEL initiates on market share buy-back program
14/03/24PRICE SENSITIVE download Created with Sketch. 89.87KB
CUV New case of SCENESSE efficacy in vitiligo presented at AAD
11/03/24PRICE SENSITIVE download Created with Sketch. 362.39KB
CUV SCENESSE Presented at American Academy of Dermatology
08/03/24 download Created with Sketch. 74.91KB
CUV Ceasing to be a substantial holder
05/03/24 download Created with Sketch. 1.12MB
CUV SCENESSE provides photoprotection in variegate porphyria
04/03/24PRICE SENSITIVE download Created with Sketch. 195.58KB
CUV Becoming a substantial holder
28/02/24 download Created with Sketch. 1.69MB
CUV Final Director's Interest Notice
27/02/24 download Created with Sketch. 188.5KB
CUV Half Year Results Webinar Recording
23/02/24 download Created with Sketch. 58.64KB
CUV CLINUVEL Delivers Increased Revenues, Solid Earnings
22/02/24 download Created with Sketch. 107.14KB
CUV CUV Appendix 4D Half Year Report
22/02/24PRICE SENSITIVE download Created with Sketch. 570.89KB
CUV Director Resignation
21/02/24 download Created with Sketch. 67.94KB
CUV CEO Letter to Shareholders
16/02/24 download Created with Sketch. 103.23KB
CUV Half Year Results Investor Webinar
16/02/24 download Created with Sketch. 59.78KB
CUV Change in substantial holding
31/01/24 download Created with Sketch. 1.58MB
CUV CLINUVEL Newsletter 1 - January 2024
16/01/24 download Created with Sketch. 256.64KB
CUV Chair Elect Letter
14/12/23 download Created with Sketch. 106.04KB
CUV Change to Registered Office
07/12/23 download Created with Sketch. 129.35KB
CUV Notification of cessation of securities - CUV
27/11/23 download Created with Sketch. 21.49KB
CUV Change of Director's Interest Notice
27/11/23 download Created with Sketch. 526.02KB
CUV Application for quotation of securities - CUV
27/11/23 download Created with Sketch. 25.55KB
CUV CLINUVEL Newsletter V - November 2023
24/11/23 download Created with Sketch. 481.47KB
CUV Sydney Vitiligo Presentation
10/11/23 download Created with Sketch. 874.94KB
CUV Final Director's Interest Notice
02/11/23 download Created with Sketch. 190.98KB
CUV CLINUVEL Appoints New Chair
31/10/23 download Created with Sketch. 135.75KB
CUV Results of Meeting
31/10/23 download Created with Sketch. 276.04KB
CUV CEO Presentation AGM
31/10/23 download Created with Sketch. 1.94MB
CUV Chair's Address
31/10/23 download Created with Sketch. 160.97KB
CUV CLINUVEL starts global Phase III vitiligo study
18/10/23 download Created with Sketch. 233.67KB
CUV CLINUVEL Newsletter IV - October 2023
06/10/23 download Created with Sketch. 245.17KB
CUV Board Changes after AGM
29/09/23 download Created with Sketch. 141.26KB
CUV Notice of Annual General Meeting/Proxy Form
29/09/23 download Created with Sketch. 577.45KB
CUV Change of Director's Interest Notice
20/09/23 download Created with Sketch. 321.36KB
CUV CEO Letter to Shareholders
19/09/23 download Created with Sketch. 192.64KB
CUV CLINUVEL Confirms AGM Date
13/09/23 download Created with Sketch. 117.29KB
CUV CLINUVEL Vitiligo Expert Panel
12/09/23 download Created with Sketch. 217.38KB
CUV SCENESSE in Adolescent EPP Study
05/09/23 download Created with Sketch. 228.91KB
CUV CLINUVEL Investor Webinar Transcript
30/08/23 download Created with Sketch. 895.6KB
CUV Appendix 4G and Corporate Governance Statement
29/08/23 download Created with Sketch. 579.18KB
CUV CLINUVEL delivering increases in annual revenue, profit
29/08/23 download Created with Sketch. 271.69KB
CUV Dividend/Distribution - CUV
29/08/23 download Created with Sketch. 22.38KB
CUV Appendix 4E and Annual Report to Shareholders 2023
29/08/23PRICE SENSITIVE download Created with Sketch. 12.68MB
CUV Annual Results Investor Webinar - time
28/08/23 download Created with Sketch. 131.05KB
CUV Technical Note - CUV151 results DNA Damage
15/08/23 download Created with Sketch. 365.52KB
CUV afamelanotide reduces DNA damage in healthy population
15/08/23 download Created with Sketch. 203.48KB
CUV SCENESSE applied under 5 year US Veterans Affairs contract
26/07/23 download Created with Sketch. 140.08KB
CUV CLINUVEL secures IP for melanocortins to treat CNS disorders
14/07/23 download Created with Sketch. 641.45KB
CUV Notification regarding unquoted securities - CUV
30/06/23 download Created with Sketch. 25.38KB
CUV Two Grounds of Appeal Upheld by NICE Panel
30/06/23 download Created with Sketch. 112.15KB
CUV Notification of cessation of securities - CUV
29/06/23 download Created with Sketch. 21.48KB
CUV Presentation - Melbourne Twilight Briefing
29/06/23 download Created with Sketch. 1.08MB
CUV Change of Director's Interest Notice
28/06/23 download Created with Sketch. 313.22KB
CUV CLINUVEL Newsletter III - June 2023
26/06/23 download Created with Sketch. 303.33KB
CUV Strategic Update VI
01/06/23 download Created with Sketch. 1.84MB
CUV PRENUMBRA administered to moderate & severe stroke patients
09/05/23 download Created with Sketch. 165.07KB
CUV Expansion of global porphyria programs
01/05/23 download Created with Sketch. 136.22KB
CUV CLINUVEL Newsletter II - April 2023
05/04/23 download Created with Sketch. 425.3KB
CUV Investor Presentation - NYC Nasdaq Event
30/03/23 download Created with Sketch. 4.12MB
CUV Technical Note - CUV803 Study and AIS
20/03/23 download Created with Sketch. 444.01KB
CUV First stroke patient treated with PRENUMBRA Instant
20/03/23 download Created with Sketch. 271.53KB
CUV DNA Repair data presented at AAD Meeting
17/03/23 download Created with Sketch. 119.77KB
CUV Statement on Silicon Valley Bank
13/03/23 download Created with Sketch. 89.95KB
CUV Proposed issue of securities - CUV
10/03/23 download Created with Sketch. 24.54KB
CUV Commercial Update SCENESSE
09/03/23 download Created with Sketch. 127.84KB
CUV Relief from Quarterly Reporting
02/03/23 download Created with Sketch. 82.33KB
CUV CLINUVEL launches first dermatocosmetic product
01/03/23 download Created with Sketch. 254.92KB
CUV Proposed issue of securities - CUV
28/02/23 download Created with Sketch. 24.53KB
CUV Global SCENESSE demand drives increased revenues, earnings
24/02/23 download Created with Sketch. 165.94KB
CUV CUV Appendix 4D Half Year Report
24/02/23PRICE SENSITIVE download Created with Sketch. 874.85KB
CUV PRENUMBRA formulation completed for clinical trial use
15/02/23 download Created with Sketch. 257.84KB
CUV Chair's Letter
09/02/23 download Created with Sketch. 215.25KB
CUV Technical note - CUV151 results
02/02/23 download Created with Sketch. 370.66KB
CUV Afamelanotide reduces UV skin damage in a healthy population
02/02/23 download Created with Sketch. 168.07KB
CUV Quarterly Activities/Appendix 4C Cash Flow Report
31/01/23PRICE SENSITIVE download Created with Sketch. 229.38KB
CUV NEURACTHEL manufacturing processes advance
23/01/23 download Created with Sketch. 359.1KB
CUV Technical Note - Xeroderma Pigmentosum
16/01/23 download Created with Sketch. 609.83KB
CUV afamelanotide Reduces DNA Photodamage in XP
16/01/23 download Created with Sketch. 333.77KB
CUV CLINUVEL Newsletter I - January 2023
10/01/23 download Created with Sketch. 510.39KB
CUV CLINUVEL Newsletter VI - December 2022
23/12/22 download Created with Sketch. 246.06KB
CUV Notification of cessation of securities - CUV
21/12/22 download Created with Sketch. 21.48KB
CUV Presentation - Jefferies London Healthcare Conference
17/11/22 download Created with Sketch. 3.31MB
CUV CLINUVEL Newsletter V - November 2022
09/11/22 download Created with Sketch. 546.94KB
CUV Change of Director's Interest Notice
07/11/22 download Created with Sketch. 216.26KB
CUV Quarterly Activities/Appendix 4C Cash Flow Report Re-issued
31/10/22PRICE SENSITIVE download Created with Sketch. 348.75KB
CUV Quarterly Activities/Appendix 4C Cash Flow Report
31/10/22PRICE SENSITIVE download Created with Sketch. 347.86KB
CUV Results of Meeting
26/10/22 download Created with Sketch. 144.34KB
CUV Chair Address
26/10/22 download Created with Sketch. 321.32KB
CUV Melbourne Investor Briefing Presentation
21/10/22 download Created with Sketch. 2.68MB
CUV First vitiligo patient enrolled in monotherapy study
20/10/22 download Created with Sketch. 151.05KB
CUV Investor Presentation - Sydney
14/10/22 download Created with Sketch. 3.31MB
CUV Notice of Annual General Meeting/Proxy Form
23/09/22 download Created with Sketch. 3.86MB
CUV Strategic Update V
19/09/22 download Created with Sketch. 408.93KB
CUV Presentation - HC Wainright Global Investment Conference
13/09/22 download Created with Sketch. 869KB
CUV Annual General Meeting Date
08/09/22 download Created with Sketch. 391.42KB
CUV CLINUVEL submits label expansion for adolescent EPP patients
05/09/22 download Created with Sketch. 157.73KB
CUV S&P DJI Announces September 2022 Quarterly Rebalance
02/09/22PRICE SENSITIVE download Created with Sketch. 134KB
CUV CLINUVEL Investor Webinar Financial Results 2022
31/08/22 download Created with Sketch. 2.1MB
CUV Appendix 4G and Corporate Governance Statement
30/08/22 download Created with Sketch. 2.57MB
CUV Revenue Growth Drives CLINUVEL's Full Year Profit
30/08/22 download Created with Sketch. 309.29KB
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.